Pooja Hingorani Selected Research

palifosfamide lysine

9/2009

Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pooja Hingorani Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 05/2009
17	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 05/2009
7	Rhabdomyosarcoma 01/2021 - 09/2009
7	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 09/2009
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 09/2009
3	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2009
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Sudden Death 01/2022
1	Infections 01/2021
1	Central Nervous System Neoplasms 01/2021
1	Pinealoma (Pineoblastoma) 01/2021
1	Desmoplastic Small Round Cell Tumor 01/2020
1	Glioma (Gliomas) 12/2019
1	Exanthema (Rash) 12/2019
1	Arthralgia (Joint Pain) 12/2019
1	Hemangioma (Angioma) 01/2019
1	Neutropenia 01/2019
1	Choriocarcinoma 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Cardiac Arrhythmias (Arrythmia) 01/2016
1	Virus Diseases (Viral Diseases) 01/2014
1	Hemorrhagic Cystitis 09/2009
1	Brain Diseases (Brain Disorder) 09/2009

Drug/Important Bio-Agent (IBA)

4	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2010
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Biological ProductsIBA 01/2021 - 04/2010
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 12/2019 - 01/2016
2	dabrafenibIBA 12/2019 - 12/2019
2	Bevacizumab (Avastin)FDA Link 11/2019 - 10/2012
2	Monoclonal AntibodiesIBA 10/2016 - 07/2010
2	Immune Checkpoint InhibitorsIBA 10/2016 - 01/2015
1	Messenger RNA (mRNA)IBA 01/2022
1	Immunotoxins (Immunotoxin)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	dinutuximabIBA 01/2022
1	CytokinesIBA 01/2022
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	trastuzumab deruxtecanIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	monomethyl auristatin EIBA 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	TransferasesIBA 01/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	NucleotidesIBA 01/2021
1	olaratumabIBA 01/2021
1	temsirolimus FDA Link 11/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	EnzymesIBA 01/2019
1	eribulin FDA Link 01/2019
1	GlypicansIBA 01/2019
1	halichondrin BIBA 01/2019
1	Propranolol (Inderal)FDA LinkGeneric 01/2019
1	CAM 5.2 antigenIBA 01/2019
1	AntigensIBA 10/2016
1	Cancer VaccinesIBA 10/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015
1	LigandsIBA 04/2015
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013
1	sepantroniumIBA 01/2013
1	Inhibitor of Apoptosis ProteinsIBA 01/2013
1	SurvivinIBA 01/2013
1	Gemcitabine FDA Link 10/2012
1	Docetaxel (Taxotere)FDA Link 10/2012
1	Antiviral Agents (Antivirals)IBA 02/2012
1	Cytotoxins (Cytolysins)IBA 04/2011
1	Cisplatin (Platino)FDA LinkGeneric 04/2011
1	Sirolimus (Rapamycin)FDA Link 07/2010
1	Immunoglobulin G (IgG)IBA 07/2010
1	teprotumumabIBA 07/2010
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2010
1	VaccinesIBA 04/2010
1	Acrolein (Aqualin)IBA 09/2009
1	isophosphamide mustard (IPAM)IBA 09/2009
1	ProdrugsIBA 09/2009
1	palifosfamide lysineIBA 09/2009
1	Ifosfamide FDA LinkGeneric 09/2009
1	src-Family KinasesIBA 05/2009
1	Dasatinib (BMS 354825)FDA Link 05/2009
1	Phosphotransferases (Kinase)IBA 05/2009
1	Dihydrotachysterol (AT 10)IBA 05/2009

Therapy/Procedure

17	Therapeutics 01/2022 - 04/2010
7	Drug Therapy (Chemotherapy) 01/2021 - 04/2010
2	Investigational Therapies (Experimental Therapy) 01/2020 - 01/2018
2	Radiotherapy 11/2019 - 04/2011
2	Immunotherapy 10/2016 - 01/2015
2	Oncolytic Virotherapy 01/2014 - 02/2012
1	Duration of Therapy 12/2019